The Institute for Biotechnology and Medicine Industry said Tuesday it has developed a safer and more convenient vaccine against human respiratory syncytial virus (RSV), which causes tens of millions of infections worldwide every year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Illustrator brings Taiwan's warmth to London buses
12/13/2025 09:05 PM - Politics
Matsu defense commander demoted over bank account scandal
12/13/2025 08:38 PM - Culture
1st Taiwan-India co-produced movie brings cultures together: Filmmakers
12/13/2025 07:17 PM - Society
Control Yuan identifies factors behind foreign residents' traffic incidents
12/13/2025 05:37 PM - Business
Taiwan, EU hold high-level trade talks to strengthen partnership
12/13/2025 04:57 PM